Herceptin (trastuzumab): Herceptin Solvent Vials/20ml co-packaged with Herceptin Powder for Injection 440mg (SIN11028P) – Voluntary recall of batches N3928B04, N3930B03, N3931B03 and N3931B07

A Dear Healthcare Professional Letter has been issued by Roche Singapore Pte Ltd to update healthcare professionals on the voluntary recall of four batches of Herceptin Solvent Vials/20ml due to the possible presence of glass particulate matter. The Herceptin Solvent Vials are co-packaged with Herceptin Powder for Injection 440mg vials. Healthcare professionals are advised to refer to the letter for further details, including the management of the recall of the product.
Healthcare professional, Industry member, Therapeutic Products
Published:

Dear Healthcare Professional Letters

1 Jul 2020

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.moh.gov.sg/hpp/, and follow the procedures below to access the MOH Alert system.

Step 1: On the top navigation ribbon of webpage, select 'For Healthcare Professionals' followed by 'Health Professionals Portal' and click on the choice of profession. User will be redirected to the specific HPP webpage for the selected profession.

Step 2: Click on the Restricted Content icon on the left panel of webpage and login via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’ section

Step 4: Click on the Drug Alert tab to view the DHCPLs.